Souhaitez-vous accéder aux communiqués récents ?

Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6–$9.8 Million, Above High End of Revised Guidance

AI-enabled facial, fingerprint, iris, and multimodal biometrics are transforming medical devices, remote monitoring, and digital healthcare.

FDA grants De Novo classification to Claria Medical for device designed to improve the safety and efficiency of hysterectomy procedures

PORTLAND, Ore., July 09, 2026 (GLOBE NEWSWIRE) -- VisCardia, Inc. today announced the first U.S. patient has been implanted in its RECOVER-HF pivotal trial of VisONE™ Synchronized Diaphragmatic...

How AI is improving material design, manufacturing efficiency, quality assurance and supply chain optimization across the medical plastics industry.

PLANO, Texas, July 02, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), announced today...

                                                                          Urteste S.A. Receives U.S. Patent for the Panuri Test Gdansk, Poland – 01 July 2026 – Urteste S.A. (Warsaw Stock Exchange:...

TEMPE, Ariz., June 25, 2026 (GLOBE NEWSWIRE) -- Nectero Therapeutics announced today a first-in-human (FIH) multicenter study evaluated treatment of small- to medium-sized abdominal aortic aneurysms...

The analysis explores how AI-driven innovations are transforming skin disease detection, treatment planning and aesthetic dermatology procedures.

Thanks to the support of the Linda and Mike Mussallem Foundation, Octane has launched the Octane Mussallem Cardiovascular Accelerator.